The development of stereotactic body radiotherapy in the past decade: A global perspective

Simon S. Lo, Ben J. Slotman, Michael Lock, Yasushi Nagata, Matthias Guckenberger, Shankar Siva, Matthew Foote, Daniel Tan, Bin S. Teh, Nina A. Mayr, Eric L. Chang, Robert D. Timmerman, Arjun Sahgal

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.

Original languageEnglish (US)
Pages (from-to)2721-2733
Number of pages13
JournalFuture Oncology
Volume11
Issue number19
DOIs
StatePublished - Oct 1 2015

Keywords

  • global
  • stereotactic body radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The development of stereotactic body radiotherapy in the past decade: A global perspective'. Together they form a unique fingerprint.

  • Cite this

    Lo, S. S., Slotman, B. J., Lock, M., Nagata, Y., Guckenberger, M., Siva, S., Foote, M., Tan, D., Teh, B. S., Mayr, N. A., Chang, E. L., Timmerman, R. D., & Sahgal, A. (2015). The development of stereotactic body radiotherapy in the past decade: A global perspective. Future Oncology, 11(19), 2721-2733. https://doi.org/10.2217/fon.15.220